On December 3, 2025, Revelation Biosciences approved a stockholder resolution to extend the expiration date of certain warrants to December 3, 2030, allowing potential issuance of common stock exceeding 20% of total shares. Additionally, 2,460,527 shares were voted at a special meeting, with substantial approval for the issuance and adjournment proposals.